News

CVS Health (NYSE:CVS) has been hit with two lawsuits from major hospital systems tied to the federal 340B drug discount program. The University of Kansas Hospital Authority and the University of Michigan Hospitals and Health Centers allege CVS Health improperly profited from 340B discounts. Combined claimed damages exceed $60 million, raising legal, financial, and reputational questions for the company. CVS Health comes into this legal pressure with its shares at $93.28 and a return of...

Claire's filed for Chapter 11 bankruptcy in August 2025, the chain's second bankruptcy filling in seven years.

DHR's Biotechnology segment posts 7% core revenue growth as bioprocessing demand stayed strong and equipment orders jumped despite headwinds.

CVS is more than a dividend play.

Takeda confirmed it would appeal the outcome, stating that the case “lacks merit”.

The president’s financial disclosures reveal several trades in UnitedHealth and other insurers as the government set Medicare rate policies.

Looking past stocks because they trade at high trailing earnings multiples can be a costly mistake for investors.

Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution. They negotiate rebates, design formularies, adjudicate claims, and steer patient adherence. Modern artificial intelligence (AI) is designed to compress each of these high-volume, rules-driven processes. As autonomous prior authorization, real-time formulary optimization, and AI-driven rebate analytics scale, the Big Three PBMs face a ... AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

A licensing agreement with Centric Brands will scale the retailer’s presence across partners, including Walmart, Kohl’s and CVS and will push the brand into new categories.

Over the past year, many CVS Health Corporation ( NYSE:CVS ) insiders sold a significant stake in the company which may...

We recently published Jim Cramer’s Latest Thoughts On Cisco, NVIDIA & Other AI Stocks. CVS Health Corp. (NYSE:CVS) is one the stocks discussed by Jim Cramer. Health insurer CVS Health Corp. (NYSE:CVS) is another stock that popped on Jim Cramer’s radar. The shares are up by 58.6% over the past year and by 19.7% year-to-date. […]

CVS Health’s first quarter results drew a significant positive market reaction, with performance driven by disciplined cost management, margin expansion, and continued improvement at Aetna. Management credited strong execution in medical cost containment and operational streamlining, particularly within the Health Care Benefits segment, as key factors. CEO David Joyner stated, “We are driving improved results at Aetna, while removing friction for members and providers.” Pharmacy & Consumer Welln

CVS Health (NYSE:CVS) has agreed to sell its Omnicare long-term care pharmacy business to GenieRx Holdings, with the transaction now approved. The company has also introduced CVS Air Response, a drone-enabled healthcare logistics and emergency support network built with SkyfireAI and Thales Aerospace. These moves reflect a refocus on core operations and new delivery channels for pharmacy and healthcare services. For investors tracking NYSE:CVS, these announcements come alongside recent...

Our 24/7 Wall St. price target for CVS Health (NYSE:CVS) is $125.45, pointing to meaningful upside from where shares trade today. The stock closed at $86.86 on May 6, after a 7.65% single-day pop on Q1 earnings. Our model implies 44.43% upside over the next 12 months, and we are issuing a buy rating with ... Price Prediction: CVS Eyes 44% Upside After Aetna-Driven Q1 Surge

CVS Health Corp. (NYSE:CVS) is one of the cheap stocks to buy for the next 10 years. On May 6, CVS Health Corporation reported Q1 2026 results, with total revenues increasing 6.2% year-over-year to $100.4 billion. The company achieved a GAAP diluted EPS of $2.30 and an Adjusted EPS of $2.57, up from $1.41 and […]

Spiking energy prices have pushed inflation to a three-year high of 3.8%. Investors expect price pressures related to the Iran war to ease—one reason the stock market keeps chugging along. Retirees who collect Social Security should get a bigger raise next year.

Investors received two reminders of how well the company did in its first quarter.

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.16%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.87%. June E-mini S&P futures (ESM26 ) fell -0.16%, and June E-mini Nasdaq futures...

NVIDIA, Mastercard and AbbVie headline Zacks' top stock reports, with AI growth, payment trends and drug launches in focus.

With an annual dividend yield of 2.88%, CVS Health Corporation (NYSE:CVS) is included among the 12 Best Blue Chip Dividend Stocks to Buy Now. America’s leading health solutions company, CVS Health Corporation (NYSE:CVS) provides advanced health care from pharmacy services and health plans to health and wellness. On May 8, Wells Fargo analyst Stephen Baxter slightly raised […]

​CVS Health Corporation (NYSE:CVS) is one of the Best Undervalued Stocks to Buy Under $100. On May 5, the company announced that its pharmacy benefit arm is updating its commercial formularies effective July 1, 2026. This shift is aimed at lower-cost biosimilars over brand-name reference drugs. ​Management noted that the most prominent change includes replacing […]

The healthcare giant's stock is up after it posted another solid quarter, which showed a big improvement in its bottom line.

More than 20 years after it redefined fast shipping, Amazon is preparing to raise the bar on consumer expectations again by offering to fulfill customers' most urgent product needs in a half-hour or less for an extra fee. The company, which revolutionized online shopping in 2005 with two-day deliveries for Prime members, is rapidly opening small order-processing hubs in dozens of U.S. and foreign cities to cater to shoppers who can't or don't want to wait for cough medicine to relieve flu symptoms or tomatoes for tonight's dinner salad. The ultrafast service, called Amazon Now, first launched in India last June.

CVS Health (NYSE:CVS) expanded its MinuteClinic partnership with Hartford HealthCare to offer adult primary care at all Connecticut locations. Aetna Better Health, a CVS Health business, is providing funding to community health initiatives in Missouri focused on underserved populations. For investors tracking NYSE:CVS, these updates sit alongside a share price of $92.22 and strong recent momentum, with the stock up 12.4% over the past week and 16.2% over the past month. Returns of 15.1%...

CVS Health (CVS) shares have reclaimed their 50-day moving average and are challenging their all-time high around $95 following an eight-month consolidation period. The stock currently maintains a 72% “Buy” technical opinion from Barchart, signaling strong alignment across short, medium, and long-term timeframes. This level for that indicator has been...

CVS Health (CVS) is back in focus after first quarter 2026 results and raised full year guidance, with management highlighting broad based strength across Aetna, Health Services, and Pharmacy & Consumer Wellness. See our latest analysis for CVS Health. After the earnings beat and guidance raise, the share price has climbed to US$90.55, with a 1 month share price return of 14.14% and a 1 year total shareholder return of 44.83%. This suggests momentum has picked up recently compared with longer...

Healthcare stocks have had a rough stretch. Rising medical costs, Medicaid pressure, and persistent skepticism about managed care margins have kept investors on edge all year. Walking into a CVS Health earnings report in that environment felt like bracing for bad news. The bad news, however, didn't ...

CVS Health (NYSE:CVS) raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations. On the company’s first-quarter earnings call, David Joyn